18.100
−0,55%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -33.5% | +23.9% | 2 / 3 | -44.7% | +15.87 pp | +2.83 pp | +7.2% | 0.03 | 23.21 | 20,3 | −44,7% | 2,4 | −27,1% | 23.21 | 24.90 | −6,8% |
| Pts | 0 | 0 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 18.100 (close price on 2026-10-19)EPS (TTM): 780,0
Financial charts
1.Revenue & growth
VND bn20,3Q2/26
1.Revenue & growth
VND bn20,3Q2/26
2.Profit & growth
VND bn2,22Q2/26
3.Profit mix (Penman)
VND bn27,3Q2/26
4.Margins & cost structure
%30.2%Q2/26
5.Returns & cash cycle
% · days7.6%Q2/26
6.Earnings quality & cash
VND bn29,1Q2/26
7.Asset structure
VND bn302Q2/26
8.Funding & debt health
VND bn · times302Q2/26
9.Revenue backlog
VND bn0,06Q2/26
10.Valuation
times · %24,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %87Q2/26
Adjusted EPS growth, latest quarter
-28.8%
Average adjusted EPS growth, 3 quarters
25.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26